Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.

Douglas B KellMare VlokChantelle VenterJohannes A BezuidenhoutGert Jacobus LaubscherJanami SteenkampDouglas B Kell

Published in: Cardiovascular diabetology (2021)

Clotting pathologies in both acute COVID-19 infection and in Long COVID/PASC might benefit from following a regime of continued anticlotting therapy to support the fibrinolytic system function.

Keyphrases

coronavirus disease
sars cov
liver failure
respiratory failure
drug induced
respiratory syndrome coronavirus
stem cells
small molecule
mesenchymal stem cells
extracorporeal membrane oxygenation
protein protein